Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Year: 2026
Type: article
Abstract: Liver X receptors (LXRs), comprising LXRα and LXRβ, are oxysterol-responsive nuclear receptors that regulate cholesterol homeostasis and inflammatory signaling. In the central nervous system (CNS), LXR activity influences amyloid-β metabolism, glial responses, synaptic integrity, myelination, and blood–brain barrier function. This narrative review synthesizes shared and disease-specific mechanisms across neurodegenerative and demyelinating disorders, distinguishing established experimental effects from proposed pathways. We compare representative LXR modulators by receptor and transcriptional selectivity, CNS exposure, efficacy, and safety. Particular attention is given to hepatic lipogenesis caused by systemic LXRα activation and to LXRβ-selective or function-selective ligands, brain-targeted delivery, combination strategies, and biomarker-guided patient stratification. Although preclinical findings support therapeutic potential, clinical efficacy remains unproven. Priorities include cell-type-specific causal validation, quantitative CNS target engagement, and long-term safety assessment.
Source: Biomolecules
DOI: 10.3390/biom16111654
Institutions: Zhaoqing University, Southern Medical University
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Keywords: liver X receptor, liver X receptor alpha, LXRβ, neurodegenerative diseases, demyelinating disease, oxysterols, cholesterol homeostasis, amyloid-beta metabolism, glial response, synaptic integrity, myelination, blood-brain barrier, hepatic lipogenesis, brain drug delivery, target engagement, drug safety
Open Access status: gold
Estimated APC paid: $3,258
Award: G997771359
OpenAlex ID: W7225903542
